Tuesday, March 4, 2025
More
    HomeHyderabadDCA confiscates allopathic medicine due to deceptive advertising.

    DCA confiscates allopathic medicine due to deceptive advertising.

    Related stories

    Heatwave warning: Authorities advise staying indoors

    Mahabubnagar Faces Rising Temperatures, Collector Issues Heatwave Warning ...

    Medical or legal, young team learned to help the needy during Covid

    Young Advocate Offers Free Legal Help to the NeedyIn...

    MAA E.N.T. Celebrates Over 700 Successful Cochlear Implant Surgeries

    MAA E.N.T. Celebrates World Hearing DayMAA E.N.T....

    The Telangana State Drug Control Administration (DCA) seized allopathic medicine ‘Colinol-SPAS’ tablets from a medical shop in Nampally. This was because the medicine had misleading advertisements claiming it could treat disorders of menstrual flow, which goes against the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

    The raids conducted on Tuesday and Wednesday by TSDCA officials found ‘Colinol-SPAS’ tablets manufactured and marketed by Vivimed Labs Ltd in Kashipur, Uttarakhand. The product label made a misleading claim by suggesting it can treat spasmodic dysmenorrhea and menstrual disorders.

    Making misleading claims about medicines is punishable under the Drugs and Magic Remedies Act, 1954. Those found guilty may face imprisonment for up to six months, a fine, or both.

    - Advertisement -
    Also read:  GHMC Imposes Rs 42 Lakh in Fines for Poor Construction Waste Management

    If the public has any complaints regarding illegal activities concerning medicines, they can report them to the DCA Telangana through the toll-free number: 1800-599-6969. The helpline operates between 10:30 am and 5 pm on all working days.

    - Advertisement -

    Follow us

    3,565FansLike
    179FollowersFollow
    1,202FollowersFollow
    965SubscribersSubscribe

    Contribute News

    You can contribute an article to Telangana Tribune by dropping a mail at newsdesk@telanganatribune.com

    Latest stories

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here